: iStockAnalyst.com Symbols Feed

A New Emerging Diagnostics Index

Fri, 26 Dec 2008 15:27:00 GMT

The accompanying table (click to enlarge) includes 39 companies in the ETF Innovators (ETFI) Emerging Diagnostics Index of U.S.-listed stocks with market caps of $10-$200M. The index includes diabetes care device makers such as DexCom (DXCM), personalized medicine lab service providers such as Clarient (CLRT), clinical diagnostic test developers such as OraSure (OSUR), diagnostic imaging service providers such as Virtual Radiologic (VRAD), diagnostic equipment makers such as Vision Sciences (VSCI), and genetic[More...]

15 Stocks I’m Looking At Short Selling To Increase My 216% YTD Return

Thu, 11 Dec 2008 16:38:00 GMT

Already successfully shorted one…bringing me to 235% YTD….Jeewwwww Yah! $1800 profit on the day…guess which one….This was sent to TIMalert subscribers early this morning, just... Visit TimothySykes.com to read full article with comments [More...]

Analyst Comments: DexCom, Dr. Pepper, Aetna, Array BioPharma, ConEd, Williams Companies, Dell, Tech Data, Aventine, Allscripts, Anesiva

Wed, 13 Aug 2008 12:23:00 GMT

DexCom, Inc. (DXCM) reported a second-quarter net loss of $0.48 per share compared with a net loss of $0.40 per share in the comparable period last year. We are pleased with top line product revenue growth and are encouraged by the recently announced cont[More...]

Twenty Stocks to Short Sell

Wed, 09 Jul 2008 14:26:00 GMT

Just put ‘em all in a watchlist and watch ‘em…some will go nowhere, some will spike, some will drop…aim small, miss small, learn to understand the setups that lead to the biggest drops:GETG had a nice reversal—thought about shorting into the clo0se, but now that Thinkorswim got strict about the Pattern Day Trader rule, I’m scared to short imperfect setups, kinda of a gift and a curse…no support til $3, definitely reserves shares for possible shortWLGC is a patent play, they typically runup nicely, but only if the volume is there and inevitably come crashing down, reserve shares to short just in caseARTE whaaaat? Trying to make a cup & handle breakout right into resistance at $2? Wow, this would be pretty amazing, I just can’t believe it, reserve shares just in case this breakout attempt fails…hopefully it keeps goin cuz right...[More...]

NASDAQ Technical Picture - Narrow Range Inside Bar

Fri, 09 May 2008 06:49:38 GMT

Not much to say about today's session, except snooze fest. We carved out a NRIB in the lower half of yesterday's WRB. The 15 minute chart sums it up well, a chop[More...]

Earnings Summary: Tuesday, March 11, 2008

Wed, 12 Mar 2008 06:44:48 GMT

Ticker: HLCS,DIVX,LNY,SCMP,SWSI,APEI,PLUG,DXCM,GOT,MBLX,ASHW,PNY,GPX,IRETS,ADAM,AVCA,BUCA,CAS,DKS,DMND,EXLS,GIGM,GSOL,ICFI,IDT,JCG,KR,PNTR,SAM,SSI,SVNT,CSU,ESLT,ALTU,BKE,BLTI,LACO,MDZ,SOMX,STEI,ZILA,CHTP,LXU,REVU[More...]

Cylex, Inc. Appoints Brad L. Stewart As Chief Executive Officer and Chairman of the Board

Thu, 10 Sep 2009 13:53:00 GMT

COLUMBIA, Md., Sept. 10 /PRNewswire/ -- Cylex, Inc., a venture- backed global life sciences company that develops and manufactures research and in vitro diagnostic products intended to illuminate immunity, announced today the appointment of the company's president, Brad L. Stewart, to chief executive officer and chairman of the board.
Since joining Cylex as president in December 2007, Mr. Stewart has successfully led the development of the company's commercial infrastructure, expansion internationally to 18 countries and substantial revenue growth.
"The expanded commercialization of Cylex's technology presents an exciting opportunity for the company to develop cellular diagnostics for diseases and treatments where the immune system is affected," said President, CEO and Chairman Brad L. Stewart.

[More...]

DexCom to Present at the 29th Annual Canaccord Adams Global Growth Conference

Wed, 05 Aug 2009 21:28:00 GMT

DexCom, Inc. (NASDAQ:DXCM) today announced that Steven Pacelli, Chief Administrative Officer, will present an update on DexCom at the Canaccord Adams Global Growth Conference in Boston on Tuesday, August 11, 2009 at 11:30 a.m. (EDT). The presentation, which will occur live at The InterContinental Hotel in Boston, will be concurrently webcast. The link to the webcast will be available on the DexCom, Inc. website at www.dexcom.com under the investor webcast section and will be archived for future reference.[More...]

DexCom Inc. Reports Second Quarter 2009 Financial Results

Mon, 03 Aug 2009 20:04:00 GMT

DexCom, Inc. (Nasdaq: DXCM) today reported its unaudited financial results for the quarter ended June 30, 2009.[More...]

DexCom Schedules Second Quarter 2009 Earnings Release and Conference Call for August 3, 2009

Mon, 27 Jul 2009 20:03:00 GMT

DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its second quarter 2009 financial results after market close on Monday, August 3, 2009. Management will hold a conference call to review the company's second quarter financial performance starting at 4:30 p.m. (Eastern Time) on the same day. The conference call will be concurrently webcast. The link to the webcast will be available on the DexCom, Inc. website at www.dexcom.com under the investor webcast section and will be archived for future reference.[More...]

DexCom Appoints Eric Topol, M.D. as Board Member

Thu, 09 Jul 2009 21:09:00 GMT

DexCom, Inc. (NASDAQ:DXCM) today announced the appointment of Eric Topol, M.D. as a member of DexCom’s Board of Directors.[More...]

DexCom Names Richard B. Doubleday Vice President of Sales

Wed, 10 Jun 2009 20:58:00 GMT

DexCom, Inc. (NASDAQ:DXCM) today announced that Richard B. Doubleday has been appointed to the position of Vice President of Sales where he will oversee DexCom’s sales and sales administration functions. Mr. Doubleday joins DexCom from Johnson & Johnson, where he spent over 21 years at several operating companies, including the past 13 years working in the diabetes space for both LifeScan, Inc. and Animas Corporation. Mr. Doubleday will report to Terry Gregg, DexCom’s President and Chief Executive Officer.[More...]

CORRECTING and REPLACING DexCom to Present at the 2009 William Blair Growth Stock Conference

Tue, 02 Jun 2009 16:35:00 GMT

First graph, end of first sentence of release dated June 1, 2009, time should be 1:10 p.m. (CDT) (sted 1:10 p.m. (EDT)).[More...]

DexCom to Present at the 2009 William Blair Growth Stock Conference

Mon, 01 Jun 2009 20:46:00 GMT

DexCom, Inc. (NASDAQ:DXCM) today announced that Terrance Gregg, President and Chief Executive Officer, will present an update on DexCom at the 2009 William Blair Growth Stock Conference in Chicago on Tuesday, June 9th, 2009 at 1:10 p.m. (EDT). The presentation, which will occur live at the Four Seasons Hotel in Chicago, will be concurrently webcast. The link to the webcast will be available on the DexCom, Inc. website at www.dexcom.com under the investor webcast section and will be archived for future reference.[More...]

DexCom Inc. Reports First Quarter 2009 Financial Results

Wed, 06 May 2009 20:08:00 GMT

DexCom, Inc. (Nasdaq: DXCM) today reported its unaudited financial results for the quarter ended March 31, 2009.[More...]

DexCom to Present at the Canaccord Adams Diabetes and Obesity Conference

Tue, 05 May 2009 21:19:00 GMT

DexCom, Inc. (NASDAQ:DXCM) today announced that Terrance Gregg, President and Chief Executive Officer, will present an update on DexCom at the Canaccord Adams Diabetes and Obesity Conference in New York on Tuesday, May 12, 2009 at 2:20 p.m. (EDT). The presentation, which will occur live at The InterContinental Barclay Hotel in New York City, will be concurrently webcast. The link to the webcast will be available on the DexCom, Inc. website at www.dexcom.com under the investor webcast section and will be archived for future reference.[More...]